At a glance
ClinicalIndex Comparison RecordN/ACompleted· 11 enrolled
Drug / intervention
Juvederm Volbella XC hyaluronic acid dermal filler injectionprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Evaluation of Infraorbital Filler Injection
In Brief
A clinical study evaluating Juvederm Volbella XC hyaluronic acid dermal filler injection for Dermal Filler and Rejuvenation. Completed, enrolled 11 participants across 1 site.
Detailed Summary
The goal of this clinical trial is to measure the facial volumetric changes over time in patients injected with hyaluronic acid dermal filler (Juvéderm Volbella XC) in the infraorbital (under eye) region. Participants will be injected with Juvéderm Volbella XC filler and asked to return for 3D photography at 2 weeks, 1 month, and 3 months post-injection.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDermal Filler, Rejuvenation
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartJan 2023
First PostedJan 2023
Primary CompletionApr 2023
Study CompletionJun 2023
TodayJul 2026
First PostedJan 23, 2023
Enrollment StartJan 6, 2023
Primary CompletionApr 29, 2023
Study CompletionJun 29, 2023
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 3.4 years ago
Interventions
Juvederm Volbella XC hyaluronic acid dermal filler injectionprocedure
Infraorbital filler injection